Lfjimack

Passionate about driving clinical research forward? Join us as a Clinical Trial Manager! @QMULWHRI 👩‍💻Apply here: qmul.ac.uk/jobs/vacancies… ⌛️Closing Date: 6 April #ResearchOpportunity #ClinicalTrials #ResearcherJobs

We're hiring! 🗣️ We are seeking an experienced Postdoctoral Research Assistant in histological, cellular, and molecular biology to contribute to the delivery of high-quality research at EMR @QMULWHRI 👩‍💻Apply here: qmul.ac.uk/jobs/vacancies… ⌛️Closing date: 11 March 2024

Hear more about the study and advances in RA treatment from Prof. Costantino Pitzalis @QMUL in an online talk next Monday, 20 Mar 2023, from 2 to 3.30 PM (UK time). The talk is aimed at people living with RA and their friends and family. Register here: eventbrite.co.uk/e/the-new-3tr-…

We’re excited to share that our new #3TR Clinical Study “3TR-Precis-The-RA” investigating precision therapy in patients with #RheumatoidArthritis has just started! 🙌Find out more: 3tr-imi.eu/news-and-media…

Only 6 days away!!! @NRAS_UK @VersusArthritis #PrecisionMedicine

The new 3TR Trials- the promise of Personalised Medicine for RA Tickets, Mon 20 Mar 2023 at 14:00 | Eventbrite eventbrite.co.uk/e/the-new-3tr-…

Applications are invited for a Teaching/Research Post: EMR CLINICAL SENIOR LECTURER post, at our Centre! qmul.ac.uk/jobs/vacancies… @EMR_QMUL @QMULWHRI @NHSBartsHealth at the Department of #Rheumatology

Interested in working in the vibrant EMR Centre? An excellent Research Technician opportunity, calling for applicants. Apply via, qmul.ac.uk/jobs/vacancies… #biomedicine #research #rheumatology Closing date is 27th July @FlaminGoH2020 @EMR_QMUL @QMULWHRI

The co-initiators of the #StickToScience initiative have sent an open letter to the EC President Ursula @vonderleyen asking her to intervene urgently in the critical issue for science created by the delay of the association of 🇬🇧 and 🇨🇭to #HorizonEurope. stick-to-science.eu/open-letter-to…

Chair elect of @EMEUNET @FeliceRivellese has the honour of the last talk of #ACR19 #ACR2019 presenting surprising results of a biopsy driven trial.

Data from the R4-RA trial, exploring treatment response based on synovial tissue biopsies, shows that in B-cell poor synovitis #Tocilizumab is superior compared to #Rituximab. @FeliceRivellese #ACR19

Dr. Constantino Pitzalis @QMUL @BartsHospital discusses his research into tocilizumab in RA in those w low b cell levels in synovial tissue, the world's first biopsy driven clinical trial bit.ly/2y2CdqU